CME Group, Inc., based in Chicago, is the world’s largest derivatives exchange, offering a broad array of derivatives contracts, clearing services, market data and indexes products. The publicly traded company had a market cap of $33 billion, as of October 2016.
The exchange was formed by the $11.6 billion merger in July 2007 of the 109-year-old Chicago Mercantile Exchange (CME) and the 159-year-old Chicago Board of Trade (CBOT), its former rival. It expanded further with its August 22, 2008 acquisition of energy and metals exchange NYMEX Holdings, Inc. The two acquisitions resulted in CME Group becoming the largest U.S. futures exchange, with an estimated 98 percent of the US futures volumes, as well as the largest futures exchange in the world.
CME Group ranked first in global exchange volume in 2016 with over 3.9 billion contracts traded, an 11.6 percent increase from the previous year, according to the FIA Annual Volume Report.
Chicago Mercantile Exchange
Chicago Board of Trade
New York Mercantile Exchange
|Founded||July 12, 2007 (through Chicago Mercantile Exchange Holdings and CBOT Holdings merger)|
|Headquarters||Headquarters: 20 South Wacker Drive, Chicago, IL 60606 (plus other CME Group offices domestic and international)|
|Key People||Terrence A. Duffy, Chairman and CEO; Bryan Durkin, President|
|Products||Interest rate, equity index, foreign currency, commodity futures and options and alternative investments (e.g. weather, real estate)|
CME Group offers contracts in all major asset classes:
Terrence A. Duffy, Chairman and CEO
Bryan T. Durkin, President
Kathleen Cronin, Senior Managing Director, General Counsel and Corporate Secretary
Sunil Cutinho, President, CME Clearing
Julie Holzrichter, Chief Operating Officer
Kevin Kometer, Chief Information Officer
John W. Pietrowicz, Chief Financial Officer
Hilda Harris Piell, Chief Human Resources Officer
Derek Sammann, Senior Managing Director, Global Head of Commodity and Options Products
Kim Taylor, President, Clearing and Post-Trade Services
Sean Tully, Senior Managing Director, Global Head of Financial and OTC Products
Julie Winkler, Chief Commercial Officer